Fundraising FoxBlue Bear Ventures — Full Portfolio
29 tracked investments · listed companies and verified rows first
Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials
Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)
Co-investors4DX VenturesAbstract VenturesArtis VenturesBoxGroupCalm VenturesEvolution VC Partners+13 more
Aluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases.
Digital HealthHealthtechMedical Devices
Charvi Shetty(Chief Executive Officer)inInderjit Jutla(Chief Scientific Officer)
Co-investorsGood Growth CapitalMatrixRho Capital PartnersRho VenturesSeraph GroupSOSV+1 more
Aluna Data provides a benchmarking suite for oncology AI models, offering standardized datasets including over 2 million whole slide images across 25+ tumor types with pathologist annotations, whole genome sequencing data, and clinical information for cancer research and AI development.
AI & Machine LearningBiotechDeveloper ToolsEnterprise SoftwareMedical DevicesSan Francisco, US
David Chu(CEO)inCharvi Shetty(Founder)John FinbergWill Hopkins(CTO)
Co-investorsClearSkyCreative HQ — The IncubatorTitan CapitalY Combinator
Ayar Labs develops co-packaged optics (CPO) technology for AI infrastructure, enabling optical connectivity between thousands of GPUs across data center racks.
AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US
Mark Wade(Founder)inAlex Wright-Gladstein(Founder)inChen Sun(Founder)Milos Popovic(Founder)Rajeev Ram(Founder)Vladimir Stojanovic(Founder)
Co-investorsNVIDIAAlumni VenturesBasecamp FundBerkeley FrontierCastor VenturesFactorial Funds+26 more
BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.
BiotechDigital HealthMedical DevicesSan Carlos, US
Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in
Co-investorsBerkeley Angel NetworkIllumina Accelerator
BreezeBio develops a programmable delivery platform called NanoGalaxy for targeted delivery of genetic medicines to specific cells and tissues.
BiotechDeep TechMedical Devices
Kunwoo Lee(Founder)inBreezeBio since he(Founder)Hyo Min Park(Founder)
Co-investorsBow CapitalIMM Investment JapanDCVC (Data Collective)
Clarity provides identity security and fraud protection for organizations throughout the candidate and employee lifecycle, using AI detection technology to prevent unauthorized access and insider threats caused by AI-driven identity manipulation.
AI & Machine LearningCybersecurityHR Tech
Ofer Ben-Noon(Co-Founder & CEO)Udi Mokady(Co-founder & CTO)Slavik Markovich(Head of GTM)Eyal Sasson(Head of Fraud & IP)David Lu(Founder)Gil Avriel(Founder)
Co-investorsAscend Venture CapitalBessemer Venture PartnersCommunity Access FundFlying Fish VenturesFusion VCGroundswell Ventures+15 more
Clarity provides air quality sensing-as-a-service solutions, combining hardware air pollution sensors with cloud-based monitoring software and consulting services for organizations and communities measuring air quality.
CleantechClimate TechData & InfrastructureHardwareIoT
David Lu(Founder)in
BoardMinette NavarreteinRamanan RaghavendraninMarc Tarpenningin
Co-investorsGroundswell VenturesKickstart VenturesSOSVSoundproof VenturesSpero VenturesHumba Ventures+2 more
.jpeg){kind=logo}
CoreShell Technology develops metallurgical silicon materials for electric vehicle batteries as a more economical and scalable alternative to synthetic silicon.
CleantechEnergyNew Materials
Co-investorsBaruch Future VenturesEntrada VenturesFoothill VenturesHelios Climate VenturesTrousdale VenturesZeon Ventures
Coreshell develops battery materials and technology aimed at improving battery capacity, performance, and cost while reducing reliance on critical materials.
CleantechEnergyNew MaterialsSan Leandro, US
Jonathan Tan(Founder)inSourav Basu(Executive Officer, Director)John Nadaskay(Executive Officer)inYoungduk Kim(Executive Officer)Roger Basu(Founder)
BoardBenoist Ollivier(Director)
Co-investorsAsymmetry VenturesBerkeley SkyDeck FundEntrada VenturesMana VenturesUC Berkeley SkydeckVeronorte+6 more
Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL.
BiotechDeep TechHardwareHealthtechMedical DevicesSan Francisco, US
Akwasi Apori(Founder)inKursad Araz(CTO)inSamuel Tia(Founder)in
Co-investorsBeresford VenturesCota CapitalEndurance28Pallasite VenturesPangaea Ventures Us Inc.SV Latam Capital+13 more
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardAndrew Cain McClary(Director)Drew Lanza(Director)in
Co-investorsBerkeley CatalystKdT Ventures
ImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions.
AI & Machine LearningBiotechHealthtech
Jamin Koo(Founder)Sungwon Lim(Founder)
Co-investorsDFJ DragonFundDraper AssociatesHan River PartnersPear VCPlug and Play VenturesSazze+2 more
Lockheed Martin is a global security and aerospace company that develops military aircraft, missile defense systems, helicopters, radar and sensor systems, spacecraft, and cybersecurity capabilities for the U.S.
Deep TechDefense TechHardwareSpace TechBethesda, US
Jim Taicletin
Co-investorsDefence Trailblazer
New Sun Road builds Stellar, a microgrid energy management platform combining Microgrid OS and Edge hardware that uses IoT data and AI to monitor, control, and optimize power systems such as solar and battery installations.
CleantechEnergyIoTRichmond, US
Jalel Sager(Director)inAustin Cappon(Director)inCandice Eggerss(Director)Adrienne Pierce(Executive Officer, Director)inChad Riley(Director)
BoardAndrew Karetsky(Director)
Co-investorsFocus Central AmericaSkyview Ventures
Numericcal provides machine learning software for detecting anomalies, tracking assets, and managing workforce activities in automotive and manufacturing facilities, processing video and audio data across on-premises and cloud infrastructure to reduce operating costs.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US
Shaoyi Cheng(Founder)inranko sredojevic(Founder)in
Co-investorsY Combinator
Building new drugs to target inflammation using an AI + immunology discovery engine.
BiotechHealthtechSan Francisco, US
Jason Barbour(CEO)inDavid Ott(CTO)in
Co-investorsY CombinatorFundamental VenturesMicroVentures
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
BoardVasudev Bailey(Director)in
Co-investorsAbstract VenturesArtis VenturesAsset Management CompanyBetter Ventures Central LlcColorcon VenturesDroia Ventures+9 more
.png)
YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials.
BiotechFemTechHealthtech
Akash Bakshi, MSc(Co-founder & CEO)Nadja Mannowetz, PhD(Co-founder & CSO)
Co-investorsCivilization Ventures Management, LlcForeground CapitalFuture VenturesNorth South VenturesPortfoliaOlive Tree Capital+1 more
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.
BiotechHealthtechMedical DevicesSan Francisco, US
Akash Bakshi(CEO)inNadja Mannowetz(Founder)inAndrew Bartynski(COO)Polina Lishko
Co-investorsForeground CapitalOlive Tree CapitalPortfoliaY Combinator8VCCapitoria+10 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AetherANA TherapeuticsCyprisCypris MaterialsEngagelivelyImmulus
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.